We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
- Authors
Kazuhiko Hayashi; Naoyoshi Yamamoto; Masataka Karube; Mio Nakajima; Naruhiro Matsufuji; Hiroshi Tsuji; Kazuhiko Ogawa; Tadashi Kamada; Hayashi, Kazuhiko; Yamamoto, Naoyoshi; Karube, Masataka; Nakajima, Mio; Matsufuji, Naruhiro; Tsuji, Hiroshi; Ogawa, Kazuhiko; Kamada, Tadashi
- Abstract
<bold>Background: </bold>Carbon-ion radiotherapy (CIRT) is a promising treatment for locally advanced non-small-cell lung cancer, especially for patients with inoperable lung cancer. Although the incidence of CIRT-induced radiation pneumonitis (RP) ≥ grade 2 ranges from 2.5 to 9.9%, the association between CIRT-induced RP and dosimetric parameters is not clear. Herein, we identified prognostic factors associated with symptomatic RP after CIRT for patients with non-small-cell lung cancer.<bold>Methods: </bold>Clinical results of 65 patients treated with CIRT between 2000 and 2015 at the National Institute of Radiological Sciences were retrospectively analyzed. Clinical stage II B disease (TNM classification) was the most common stage among the patients (45%). The median radiation dose was 72 Gy (68-76) relative biological effectiveness (RBE) in 16 fractions. In cases involving metastatic lymph nodes, prophylactic irradiation of mediastinal lymph nodes was performed at a median dose of 49.5 Gy (RBE). The median follow-up was 22 months.<bold>Results: </bold>Grade 2 and grade 3 RP occurred in 6 and 3 patients (9 and 5%), respectively. No patients developed grade 4 or 5 RP. Using univariate analysis, vital capacity as a percentage of predicted (%VC), forced expiratory volume in 1 s (FEV1), mean lung dose (MLD), volume of lung receiving ≥5 Gy (RBE) (V5), V10, V20 and V30 were determined to be the significant predictive factors for ≥ grade 2 RP. The receiver operating characteristic (ROC) analysis revealed the cutoff values for %VC, FEV1, MLD, V5, V10, V20 and V30 for ≥ grade 2 RP, which were 86.9%, 1.16 L, 12.5 Gy (RBE), 28.8, 29.9, 20.1 and 15.0%, respectively. In addition, the multivariate analysis revealed that %VC <86.9% (odds ratio = 13.7; p = 0.0041) and V30 ≥ 15% (odds ratio = 6.1; p = 0.0221) were significant risk factors.<bold>Conclusions: </bold>Our study demonstrated the risk factors for ≥ grade 2 RP after carbon-ion radiotherapy for patients with locally advanced lung cancer.
- Subjects
NON-small-cell lung carcinoma; PNEUMONIA; RADIOTHERAPY; OLDER patients; MULTIVARIATE analysis; CANCER radiotherapy; ADENOCARCINOMA; CANCER; LONGITUDINAL method; LUNG cancer; LUNG tumors; PROGNOSIS; RADIATION doses; SQUAMOUS cell carcinoma; RETROSPECTIVE studies; RADIATION pneumonitis; DIAGNOSIS
- Publication
Radiation Oncology, 2017, Vol 12, p1
- ISSN
1748-717X
- Publication type
journal article
- DOI
10.1186/s13014-017-0830-z